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There have been 26 previous series reported of ploidy in
squamous cell carcinoma of the head and neck. Of these 12
do not discuss survival (Danes et al., 1987; Ensley et al.,
1989; Feinmesser et al., 1990; Franzen et al., 1987a,b;
Graessel-Pietrusky & Hornstein, 1982; Hemmer & Kreidler,
1990; Johnson et al., 1985; Kaplan et al., 1986; Kearsley et
al., 1990; Olinici & Caluser, 1987; Wilson et al., 1988). Of the
remaining 14 articles, four do not state the type of treatment
the patient received (Boecking et al., 1985; Chen, 1989;
Lampe et al., 1987; Oloffson et al., 1986). In seven reports
the patients were treated by a variety of combinations of
radiotherapy, chemotherapy or surgery (Feichter et al., 1987;
Goldsmith et al., 1986; Goldsmith et al., 1987; Guo et al.,
1989; Holm, 1982; Sickle-Santanello et al., 1986; Tytor et al.,
1987).
Tytor et al. (1989) reported that aneuploid tumours of the
oral cavity were more likely to respond to preoperative
radiotherapy. Kokal et al. (1988) found, in a series of 76
patients treated initially by surgery, that patients with diploid
tumours fared better. They did not state whether their
patients had postoperative radiotherapy, but the wording of
their article suggests that they did. Furthermore the patients
in their series had tumours at various different sites and it is
well known that survival varies widely between different sites.
However they allowed for this by multivariate analysis.
We have previously reported that patients with end-stage
disease submitted to chemotherapy trials do better if they
have an aneuploid tumour (Cooke et al., 1990).
Thus there has been no report of a large number of
patients with tumours at one site treated in a similar fashion.
We report a relatively large series of patients with a tumour
of one site (the larynx) of similar stages (stages III and IV),
all submitted to surgery.
Patients
This report is based on 1,128 patients with a laryngeal
tumour seen personally by one of us (PMS) between 1963
and 1990. These patients have been treated throughout by a
uniform policy of radiotherapy for T,-T3N0 tumours not
causing stridor, and surgery for patients with palpable lymph
node metastases, advanced tumours (T4) and patients with
stridor. Two hundred and ninety-eight patients with a pre-
viously untreated squamous carcinoma were treated initially
by surgery. Unfortunately too little histological material was
available from specimens of patients seen before 1978. Histo-
logical blocks containing enough material for flow cytometry
were still available on 110 patients seen since 1978, and these
form the basis of this report.
Storage ofthe data andfollow-up
The data on all these patients have been recorded prospec-
tively, initially on cards, and for the last 10 years on a
microprocessor. Data have been kept up to date by personal
contact, and by information from general practitioners, the
Mersey Regional Cancer Registry, and the National Health
Service Register. Two patients (2%) have been lost to follow-
up.
Staging
The TNM stage of all patients was classified by the UICC
(1987) convention, with appropriate stage grouping.
General condition
The patients' performance status was recorded by the ECOG
classification (Beahrs et al., 1988).
Method
DNA measurement and classification
Thick sections from tumours were examined by flow cytome-
try, consecutive 5 g1m sections being stained by haematoxlin
and eosin to confirm the presence of tumour in all samples
studied. Briefly, nuclei were extracted from formalin fixed
paraffin embedded tissue by the method described by Hedley
et al. (1983). Multiple 50 gtm sections were dewaxed in xylene
and rehydrated through 0.5% pepsin in 0.9% NaCl with a
pH 1.5 for 30min at 37°C. The digest was then centrifuged,
washed and resuspended. After resuspension in 1 ml of phos-
phate buffered saline the digest was syringed 3-4 times to
disaggregate nuclear clumps and then filtered through 40 ym
nylon mesh. Nuclear concentrations were adjusted when
necessary to give a final concentration of 106 nuclei per ml.
DNA analysis was performed using a Profile-II flow
cytometer (Coulter Corp. Hialeh, Florida, USA). Where
possible fluorescence from 100,000 nuclei was recorded, a
minimum of 10,000 being required to give interpretable histo-
grams. Histograms were classified as aneuploid or diploid,
and only those with a coefficient of variation of less than 8%
being accepted. Tetraploid tumours, especially if they repre-
sent a small fraction of the whole section, may be difficult to
detect as the GO and GI of these tumour cells have the same
DNA content as normal cells in G2 and M. A 4c peak
accounting for more than 15% of the whole cell population
was designated aneuploid as it is unlikely that normal cells
would have such a high G2/M peak.
Analysis of the data
Qualitative data are displayed in contingency tables, and
analysed by x2. The relation between ploidy and host and
tumour factors was analysed by weighted logistic regression.
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Survival curves were drawn up by the life table method
(Armitage, 1987). Differences between survival curves were
analysed by multivariate regression analysis (Cox, 1972).
Results
Ploidy and host/tumourfactors
The relation between ploidy and the various host and tumour
factors is shown in Tables I and II. There was no statistically
significant difference between the diploid and aneuploid
tumours with respect to host factors. As regards tumour
factors, diploid tumours had a higher proportion of Stage IV
tumours, but not significant so, whereas aneuploid tumours
were more likely to arise from the supraglottic area and be
poorly differentiated.
Weighted logistic regression confirmed that neither sex
(z = 0.02) nor age (z = 0.56) nor general condition (z = 0.45)
were significantly associated with ploidy. However supraglot-
tic tumours were significantly more likely to be aneuploid
(z = 2.11, P<0.05), even more so if they were poorly differ-
entiated (z = 2.47, P<0.025). However histological grade
(z = 0.43) and stage (z = 1.51) were not independent indic-
ators of ploidy.
Survival
The 5 year adjusted survival was 50% for diploid tumours,
and 48% for aneuploid tumours. A direct comparison of
these two rates is not valid because of the differing incidence
of sites, histological grade and stage group. However, Cox's
multivariate regression showed that there was no statistically
significant difference between survival rates for diploid and
aneuploid tumours when these variable factors are taken into
account (z = 0.63). Indeed there was no significant overall
regression in this group of patients when they were analysed
for all known prognostic factors (x2 = 10.89, P + 0.09).
Node metastases
Thirty-nine patients later developed a lymph node metastasis:
26 were submitted to surgery, eight were untreated and five
had palliative radiotherapy or chemotherapy. The incidence
of histologically proven later lymph node recurrence was
31% for diploid tumours, and 45% for aneuploid tumours
(at 3 years). However, Cox's regression analysis showed that
ploidy was not a significant predictor of later node recurrence
(z= 1.00).
Discussion
In brief this series shows that ploidy was significantly related
to subsite within the larynx: supraglottic tumours were more
likely to be aneuploid, particularly if they were poorly differ-
entiated. However ploidy was not related to any other
tumour factor (stage or histological grade) nor to host fac-
tors (age, sex and general condition). Secondly, we found
that ploidy did not affect survival once confounding by the
site effect referred to above was taken into account.
We found a higher incidence of nodal metastases in aneu-
Table I Ploidy and host factors
Ploidy
Diploid Aneuploid
Sex
Men 45 37
Women 15 13
x2 0.01
Age
Mean (in years) 60.2 59.3
ECOG status
0 43 34
I-IV 15 16
Not recorded 2 0
X2i = 0.23
Table II Ploidy and tumour factors
Diploid Aneuploid
Site
Supraglottic 27 38
Glottic 9 5
Subglottic 12 0
Transglottic 12 7
X23= 15.5, P<0.01
Histology
Well differentiated 13 3
Moderately differentiated 20 19
Poorly differentiated 25 27
Ungraded 2 1
X22 5.63, P= 0.07
Stage grouping
I 0 0
II 0 0
III 31 30
IV 29 20
x2, 0.46, N.S.
ploid tumours, but this was not significant. The difference
could be due to the fact that aneuploid tumours are more
likely to be supraglottic and the latter tumours are more
likely to metastasise as the supraglottis has a well developed
external lymphatic drainage.
Our findings are at odds with some investigators, but many
published series have been small - the six series referred to in
the introduction contained only 157 patients in all, whereas
our series contained 110 patients. Furthermore the authors of
the above series did not use multivariate methods to assess
the relation ofploidy with host and tumour factors, and only
one (Kokal et al.) used multivariate analysis of survival to
allow for confounding. A meta analysis of all the reports of
squamous carcinoma of the head and neck published to date
shows that tumour DNA analysis has no prognostic signific-
ance in laryngeal cancer, though it probably does in mouth
cancer (Stell, 1991). Finally, unlike all previous series, our is
homogeneous with respect to site, stage of disease and treat-
ment.
The authors were grateful to the CRC and the NWCRF for tech-
nical support and to Mrs B. Cowley and Mrs J. Deeprose who did
the typing.
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